HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,837,670 | -84.1% | 74,304 | -76.3% | 0.25% | -82.6% |
| Q4 2022 | $17,869,331 | +13.9% | 314,048 | -20.8% | 1.43% | +7.4% |
| Q3 2022 | $15,682,000 | -15.4% | 396,617 | -5.9% | 1.33% | -15.2% |
| Q2 2022 | $18,542,000 | -24.3% | 421,403 | -31.4% | 1.57% | -18.3% |
| Q1 2022 | $24,490,000 | +79.8% | 614,090 | +104.7% | 1.92% | +178.0% |
| Q2 2021 | $13,623,000 | -27.4% | 300,000 | -33.3% | 0.69% | -44.5% |
| Q1 2021 | $18,761,000 | -6.5% | 450,000 | -4.3% | 1.24% | -45.0% |
| Q4 2020 | $20,074,000 | +38.9% | 470,000 | -14.5% | 2.26% | +48.9% |
| Q3 2020 | $14,454,000 | -14.4% | 550,000 | -12.7% | 1.52% | -41.9% |
| Q2 2020 | $16,890,000 | +4.3% | 630,000 | -30.0% | 2.61% | +20.5% |
| Q1 2020 | $16,191,000 | +1.5% | 900,000 | 0.0% | 2.17% | +44.7% |
| Q4 2019 | $15,957,000 | +242.9% | 900,000 | +200.0% | 1.50% | +198.6% |
| Q3 2019 | $4,653,000 | -50.8% | 300,000 | -45.5% | 0.50% | -47.7% |
| Q2 2019 | $9,449,000 | +4.0% | 550,000 | +10.0% | 0.96% | +6.5% |
| Q3 2018 | $9,085,000 | +38.2% | 500,000 | +54.1% | 0.90% | +41.2% |
| Q4 2017 | $6,574,000 | +89.2% | 324,500 | +62.2% | 0.64% | +89.3% |
| Q3 2017 | $3,474,000 | +95.3% | 200,000 | +44.1% | 0.34% | +65.2% |
| Q2 2017 | $1,779,000 | -54.2% | 138,775 | -53.7% | 0.20% | -52.7% |
| Q1 2017 | $3,888,000 | +9.3% | 300,000 | -16.7% | 0.43% | -52.0% |
| Q4 2016 | $3,557,000 | +49.0% | 360,000 | +80.0% | 0.90% | +57.5% |
| Q3 2016 | $2,388,000 | -71.3% | 200,000 | -58.3% | 0.57% | -43.2% |
| Q4 2015 | $8,318,000 | +69.0% | 480,000 | +120.2% | 1.00% | +171.8% |
| Q2 2015 | $4,922,000 | +16.9% | 218,000 | -48.9% | 0.37% | -20.8% |
| Q2 2014 | $4,210,000 | – | 426,300 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |